A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Clinical trial NCT03283085 · COMPLETED
Trial details
- NCT number
- NCT03283085
- Sponsor
- Shire
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-27
- Primary completion
- 2023-12-13
- Enrollment
- 557
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.